CompletedPhase 2NCT00883090
A Study of the Use of Factor XIII Concentrate in Patients With Inherited FXIII Deficiency
Studying Congenital factor XIII deficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- CSL Behring
- Principal Investigator
- Program Director, Clinical R&DCSL Behring
- Intervention
- FXIII Concentrate (Human)(biological)
- Enrollment
- 15 enrolled
- Eligibility
- All sexes
- Timeline
- 2009 – 2010
Study locations (6)
- Study Site, Dothan, Alabama, United States
- Study Site, Orange, California, United States
- Study Site, San Francisco, California, United States
- Study Site, Stockton, California, United States
- Study Site, Boston, Massachusetts, United States
- Study Site, Santa Cruz de Tenerife, Spain
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00883090 on ClinicalTrials.gov